Michael C. Donegan - Nov 30, 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Signature
/s/ Michael C. Donegan
Stock symbol
TXMD
Transactions as of
Nov 30, 2021
Transactions value $
-$15,947
Form type
4
Date filed
12/2/2021, 05:30 AM
Previous filing
Oct 1, 2021
Next filing
Mar 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXMD Common Stock Options Exercise +115K +812.26% 129K Nov 30, 2021 Direct F1
transaction TXMD Common Stock Sale -$15.9K -29.8K -23.06% $0.54 99.4K Nov 30, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Options Exercise $0 -115K -50% $0.00 115K Nov 30, 2021 Common Stock 115K $0.00 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 30, 2021, the reporting person received 115,000 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on November 24, 2021.
F2 The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $0.4819 to $0.5503 for an average weighted sale price of $0.5353. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
F5 The RSUs vest in two equal installments on November 24, 2021 and November 24, 2022.